Industry Partnerships & Commercialization

The Industry Partnerships and Commercialization (IP&C) Office at The Hospital for Sick Children (SickKids) champions the identification, development, and commercialization of cutting-edge health innovations from SickKids researchers, partnering with industry and investors to translate these innovations into impactful healthcare services and products worldwide.

SickKids Innovators

We help researchers at SickKids navigate commercialization pathways through tailored advice, contract negotiation, intellectual property protection, and more.

Find Support

Industry Partners

We enable industry partners and investors to tap into the robust innovation ecosystem at SickKids by facilitating research agreements, licensing deals, and start-up creation.

Partner With Us

Technology Portfolio

Our innovation database highlights current technologies from SickKids that are available for licensing, partnership, or other commercialization opportunities.

Browse Our Innovations

Transforming SickKids Innovation into Global Health Impact

At IP&C, our team comprises individuals with deep scientific expertise and extensive experience in patenting, licensing, commercial transactions, and startup ventures.

We go beyond traditional tech transfer roles by assisting SickKids Innovators in de-risking their discoveries, maximizing their value, and aligning with investor interests.

Discover how we connect ideas, industry, and investors to create efficient commercialization pathways at SickKids!

Image of the Peter Gilgan Centre for Research and Learning Tower at 686 Bay Street

Tap Into the Innovation Ecosystem at the SickKids Research Institute

IP&C operates out of the Peter Gilgan Centre for Research and Learning and is a division of the SickKids Research Institute – the largest hospital-based paediatric health institute in Canada.

3232 Active Clinical Research Studies

Over 600 Active Patents, 235 Total US Patents

18.3K Research Publications in Last 10 Years

Learn more about The SickKids Research Institute

Latest News

Methods of treating trinucleotide repeat expansion diseases | Christopher Pearson, PhD
Methods of treating trinucleotide repeat expansion diseases Christopher Pearson, PhD Senior Scientist | Genetics & Genome Biology Technology 1-Pager Full Bio [...]
A novel cell-penetrant delivery platform applied to a pan-Ras targeting anti-cancer therapy | Roman Melnyk, PhD
A novel cell-penetrant delivery platform applied to a pan-Ras targeting anti-cancer therapy Roman Melnyk, PhD Senior Scientist | Molecular Medicine Technology 1-Pager Lab Website [...]
Novel therapeutic compositions for degrading bacterial and fungal biofilms | P. Lynne Howell, PhD
Novel therapeutic compositions for degrading bacterial and fungal biofilms P. Lynne Howell, PhD Senior Scientist | Molecular Medicine Technology 1-Pager Lab Website [...]
SickKids Ranked One of Canada’s Top 40 Research Hospitals for 2021
SickKids Ranked One of Canada's Top 40 Research Hospitals for 2021 SickKids has once again been named one of Canada’s top research hospitals by Research Infosource. [...]